Cargando…
Epigenetics in cancer stem cells
Compelling evidence have demonstrated that bulk tumors can arise from a unique subset of cells commonly termed “cancer stem cells” that has been proposed to be a strong driving force of tumorigenesis and a key mechanism of therapeutic resistance. Recent advances in epigenomics have illuminated key m...
Autores principales: | Toh, Tan Boon, Lim, Jhin Jieh, Chow, Edward Kai-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286794/ https://www.ncbi.nlm.nih.gov/pubmed/28148257 http://dx.doi.org/10.1186/s12943-017-0596-9 |
Ejemplares similares
-
Epigenetics of hepatocellular carcinoma
por: Toh, Tan Boon, et al.
Publicado: (2019) -
Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinoma
por: Lim, Jhin Jieh, et al.
Publicado: (2022) -
JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020) -
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
por: Lim, Jhin Jieh, et al.
Publicado: (2022) -
Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells
por: Wang, Xin, et al.
Publicado: (2014)